衞士通(002268.SZ):實施限制性股票激勵計劃獲國務院國資委批覆
格隆匯 12 月 9日丨衞士通(002268.SZ)公佈,近日,公司收到國務院國資委《關於成都衞士通信息產業股份有限公司實施限制性股票激勵計劃的批覆》(國資考分[2020]622號),國務院國資委原則同意衞士通實施限制性股票激勵計劃,並請中國電科切實履行出資人職責,根據有關政策規定,通過規範的公司治理程序,認真指導衞士通規範實施限制性股票激勵計劃,並將激勵計劃的具體實施情況、相關辦法以及衞士通股本總數、國有控股持股數量以及比例等變化情況及時報告國務院國資委。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.